Characterizing Psychological Distress in Patients With Diabetic Retinal Disease: The Development of a Novel Patient-Reported Outcome Measure

Document Type

Conference Proceeding

Publication Date

6-2025

Publication Title

Investigative Ophthalmology and Visual Science

Abstract

Purpose : Diabetic Retinal Disease (DRD) leads to vision-related distress and anxiety that often is undiscovered or unaddressed by eye care providers. This project aims to develop a patient-reported outcome measure (PRO) that better captures and quantifies the vision-related psychological distress experienced by patients with DRD to improve current and inform future interventions.

Methods : As the first step toward creation of a PRO, we constructed a 76-item open-ended in-depth interview guide using input from a literature review as well as four focus groups conducted with experts in the field. A sample of 77 adult patients with DRD were interviewed. Participants represented the full disease spectrum of DRD including mild, moderate, and severe non-proliferative diabetic retinopathy (NPDR), proliferative diabetic retinopathy (PDR), and diabetic macular edema. In-depth interviews were recorded, transcribed, and coded using multiple coders and grounded theory in Atlas.ti software (version 9.5.4).

Results : Several common psychological themes emerged through qualitative analysis (Table 1). Patients with PDR as compared to patients with NPDR endorsed higher levels of distress and anxiety in all domains (Cohen’s w effect size range 0.04 to 0.42) with two domains, vision related worry (w = 0.43, p = 0.0002) and laser treatment anxiety (w = 0.40, p = 0.0004) approaching large effect sizes and reaching statistical significance on a 95% confidence interval.

Conclusions : There remains an unmet need to address the psychological distress caused by living with vision impairment due to diabetes. These findings will be used to identify and examine vision-related worry and distress by population and disease progression, advise new interventions and treatments, and provide a better understanding of benefits and barriers to these possible new treatments for DRD.

Volume

66

Issue

8

First Page

1122

Comments

Association for Research in Vision and Ophthalmology ARVO Annual Meeting, May 4-8, 2025, Salt Lake City, UT

Last Page

1122

Share

COinS